市場調査レポート
商品コード
1424969

細胞透過性ペプチド市場：タイプ別、用途別、エンドユーザー別、国別、地域別、2024年～2032年の産業分析、市場規模、市場シェア、予測

Cell Penetrating Peptide Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
表紙：細胞透過性ペプチド市場：タイプ別、用途別、エンドユーザー別、国別、地域別、2024年～2032年の産業分析、市場規模、市場シェア、予測

出版日
ページ情報
英文 299 Pages
納期
2～3営業日
カスタマイズ可能
細胞透過性ペプチド市場：タイプ別、用途別、エンドユーザー別、国別、地域別、2024年～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年01月23日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートハイライト

細胞透過性ペプチド市場規模は2023年に15億7,723万米ドルとなり、2024年から2032年にかけてCAGR 10.2%で拡大

細胞透過性ペプチド市場 - 市場力学

製薬・バイオテクノロジー企業からの需要の高まりが市場成長を牽引

活発なCPP研究開発機関として、製薬・バイオ企業や大学の研究機関が市場に関与しています。例えば、ペンシルバニア大学ペレルマン医学部が開発した優れた遺伝子編集法は、次世代の遺伝子・細胞治療法を促進する可能性があるとペンシルバニア大学医学部は発表しています。CRISPR遺伝子編集法は、特殊な細胞透過性ペプチドに基づくもので、生物学的ゲノムを改変する現在の方法よりも優れた潜在的利点を提供します。これにより、予測期間中の市場成長を牽引します。

細胞透過性ペプチド市場 -主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約10.2%のCAGRで毎年成長すると予測されています。

市場セグメンテーションによると、2023年には合成CPPが最大の市場シェアを示すと予測されています。

用途別では、ドラッグデリバリーが2023年の主要タイプです。

エンドユーザー別では、製薬会社およびバイオテクノロジー会社が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

細胞透過性ペプチド市場 -セグメンテーション分析：

細胞透過性ペプチドの世界市場は、タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって3つのカテゴリーに分けられる：合成CPP、タンパク質由来CPP、キメラCPPです。市場は主に合成CPPが支配的です。特定の合成CPPは、複数の機能性を有するように特別に設計されており、様々なペイロードの同時投与や治療・診断機能の統合を可能にしています。

市場は用途によって5つのカテゴリーに分けられる：ドラッグデリバリー、遺伝子デリバリー、診断、分子イメージング、その他です。市場の主役はドラッグデリバリーです。細胞透過性ペプチド（CPP）は、多様な治療薬の細胞内輸送を可能にする卓越した能力を持っているため、ドラッグデリバリーの分野で大きな注目を集めています。

市場はエンドユーザーによって4つのカテゴリーに分けられる：製薬・バイオテクノロジー企業、CRO（医薬品開発業務受託機関）、病院・診療所、その他です。市場は主に製薬・バイオテクノロジー企業が支配しています。CPPは機能ゲノミクス研究に使用され、遺伝子発現を操作し、細胞機能を調査する手段を提供します。

細胞透過性ペプチド市場 -地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカに広がっています。これらの地域は、事業活動を行っている国に基づいてさらに分割されます。市場の成長は、主に慢性疾患や感染症などの疾患の有病率の増加により、北米が支配的であると予測されています。ドラッグデリバリーのためのCPPベースのソリューションを含む革新的な治療アプローチに対する需要は、これらの疾患の罹患率と有病率の上昇に牽引されています。一般に不治の病であり現在も進行中の慢性疾患は、約1億3,300万人のアメリカ人を罹患させ、国の総人口の40％以上を占めています。2020年には、この数は推定1億5,700万人に達し、8,100万人が複数の疾患を抱えていると予測されています。欧州は、主にヘルスケア支出の増加により、市場成長において2番目に大きな地域となっています。

細胞透過性ペプチド市場 -競合情勢：

細胞透過性ペプチド（CPPs）市場は、細胞プロセスを理解するための基礎研究における需要の増加や、遺伝子治療、がん、神経科学に関連する研究における細胞内デリバリーのツールとしての役割により、著しい成長を遂げています。ナノテクノロジー、遺伝子編集、その他のバイオテクノロジーの分野も進歩しており、市場に新たな競争相手や補完的技術を導入する可能性があります。CPPは、治療用分子の細胞内送達を促進する可能性があるため、様々な分野、特にドラッグデリバリーで大きな注目を集めています。そのため、細胞透過性ペプチドの市場を分析する際には、競合分析と用途に応じた需要を考慮することが極めて重要です。

目次

第1章 細胞透過性ペプチド市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 細胞透過性ペプチドの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 細胞透過性ペプチド産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 細胞透過性ペプチド市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 細胞透過性ペプチド市場情勢

  • 細胞透過性ペプチド市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 細胞透過性ペプチド市場 - タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 合成CPP
    • タンパク質由来のCPP
    • キメラCPP

第8章 細胞透過性ペプチド市場 - 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • ドラッグデリバリー
    • 遺伝子導入
    • 診断
    • 分子イメージング
    • その他

第9章 細胞透過性ペプチド市場 - エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 製薬会社・バイオテクノロジー会社
    • 受託研究機関（CRO）
    • 病院と診療所
    • その他

第10章 細胞透過性ペプチド市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - 細胞透過性ペプチド産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Pepscan
    • Creative Peptides
    • Cupidpeptides
    • AltaBioscience Ltd
    • AnaSpec
    • Peptomyc
    • BioAlps
    • Sarepta Therapeutics, Inc.
    • REVANCE THERAPEUTICS
    • PolyPeptide Group
    • Bachem
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell Penetrating Peptide Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Cell Penetrating Peptide Market, by Type 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Cell Penetrating Peptide Market, by Application 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell Penetrating Peptide Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell Penetrating Peptide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell Penetrating Peptide Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell Penetrating Peptide Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2169

REPORT HIGHLIGHT

Cell Penetrating Peptide Market size was valued at USD 1,577.23 Million in 2023, expanding at a CAGR of 10.2% from 2024 to 2032.

Cell-penetrating peptides (CPPs) are a broad class of short peptides that can penetrate cell membranes without compromising their structural or functional integrity. They have been extensively studied for their potential to transport therapeutics, bioactive molecules, and theragnostic cargoes inside of cells. Since these characteristics make therapeutically important macromolecules less permeable via biological membranes, they are especially desired.

Cell Penetrating Peptide Market- Market Dynamics

Growing demand from pharmaceutical & biotechnology companies drives market growth

As active CPP research and development organizations, pharmaceutical and biotechnology businesses as well as university research institutions are involved in the market. For instance, a better gene editing method created by the University of Pennsylvania's Perelman School of Medicine may fuel the next generation of gene and cell treatments, according to a Penn Medicine paper. The CRISPR gene editing method, which is based on special cell-penetrating peptides, offers potential advantages over current methods for altering biological genomes. Thereby, driving the market growth over the forecast period.

Cell Penetrating Peptide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.2% over the forecast period (2024-2032)

Based on Type segmentation, Synthetic CPPs were predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on End-User segmentation, Pharmaceutical and Biotechnology Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell Penetrating Peptide Market- Segmentation Analysis:

The Global Cell Penetrating Peptide Market is segmented based on Type, Application, End-User, and Region.

The market is divided into three categories based on Type: Synthetic CPPs, Protein-derived CPPs and Chimeric CPPs. The market is predominantly dominated by synthetic CPPs. Certain synthetic CPPs have been specifically engineered to possess multiple functionalities, enabling the concurrent administration of various payloads or the integration of therapeutic and diagnostic capabilities.

The market is divided into five categories based on application: Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging and Others. The market is primarily dominated by the Drug Delivery segment. Cell-penetrating peptides (CPPs) have attracted considerable attention in the drug delivery field because of their exceptional capability to enable the intracellular transportation of diverse therapeutic agents.

The market is divided into four categories based on End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals and Clinics and Others. The market is predominantly controlled by Pharmaceutical and Biotechnology Companies. CPPs are employed in functional genomics research, providing means to manipulate gene expression and investigate cellular functions.

Cell Penetrating Peptide Market- Geographical Insights

Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is projected to be dominated by North America, primarily due to the increasing prevalence of diseases such as chronic and infectious diseases. The demand for innovative therapeutic approaches, including CPP-based solutions for drug delivery, is driven by the rising incidence and prevalence of these conditions. Chronic diseases, which are generally incurable and ongoing, affect approximately 133 million Americans, accounting for more than 40% of the country's total population. By 2020, this number is projected to reach an estimated 157 million, with 81 million individuals having multiple conditions, as reported by the National Health Council. Europe holds the second largest region for market growth, mainly due to the rising healthcare expenditure.

Cell Penetrating Peptide Market- Competitive Landscape:

The market for cell penetrating peptides (CPPs) is witnessing significant growth due to the increasing demand in basic research to understand cellular processes and their role as tools for intracellular delivery in studies related to gene therapy, cancer, and neuroscience. The field of nanotechnology, gene editing, and other biotechnologies is also advancing, which may introduce new competitors or complementary technologies in the market. CPPs have garnered considerable attention in various fields, particularly drug delivery, due to their potential for facilitating the intracellular delivery of therapeutic molecules. Therefore, when analyzing the market for cell-penetrating peptides, it is crucial to consider competition analysis and demand in the context of their applications.

Recent Developments:

In July 2023, the U.S. FDA accepted Revance Therapeutics, Inc.'s additional biologic license application for DAXXIFY, which is intended to treat adult cervical dystonia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL PENETRATING PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pepscan

Creative Peptides

Cupidpeptides

AltaBioscience Ltd

AnaSpec

Peptomyc

BioAlps

Sarepta Therapeutics, Inc.

REVANCE THERAPEUTICS

PolyPeptide Group

Bachem

Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Synthetic CPPs
  • Protein-derived CPPs
  • Chimeric CPPs

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics
  • Others

GLOBAL CELL PENETRATING PEPTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell Penetrating Peptide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell Penetrating Peptide Market Snippet by Type
    • 2.1.2. Cell Penetrating Peptide Market Snippet by Application
    • 2.1.3. Cell Penetrating Peptide Market Snippet by End-User
    • 2.1.4. Cell Penetrating Peptide Market Snippet by Country
    • 2.1.5. Cell Penetrating Peptide Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell Penetrating Peptide Key Market Trends

  • 3.1. Cell Penetrating Peptide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell Penetrating Peptide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell Penetrating Peptide Market Opportunities
  • 3.4. Cell Penetrating Peptide Market Future Trends

4. Cell Penetrating Peptide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell Penetrating Peptide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell Penetrating Peptide Market Landscape

  • 6.1. Cell Penetrating Peptide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell Penetrating Peptide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Synthetic CPPs
    • 7.1.3. Protein-derived CPPs
    • 7.1.4. Chimeric CPPs

8. Cell Penetrating Peptide Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Drug Delivery
    • 8.1.3. Gene Delivery
    • 8.1.4. Diagnostics
    • 8.1.5. Molecular Imaging
    • 8.1.6. Others

9. Cell Penetrating Peptide Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Contract Research Organization (CROs)
    • 9.1.4. Hospitals and Clinics
    • 9.1.5. Others

10. Cell Penetrating Peptide Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell Penetrating Peptide Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell Penetrating Peptide Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell Penetrating Peptide Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cell Penetrating Peptide Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cell Penetrating Peptide Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell Penetrating Peptide Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pepscan
    • 11.2.2. Creative Peptides
    • 11.2.3. Cupidpeptides
    • 11.2.4. AltaBioscience Ltd
    • 11.2.5. AnaSpec
    • 11.2.6. Peptomyc
    • 11.2.7. BioAlps
    • 11.2.8. Sarepta Therapeutics, Inc.
    • 11.2.9. REVANCE THERAPEUTICS
    • 11.2.10. PolyPeptide Group
    • 11.2.11. Bachem
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us